Romuald Le Scodan

Saint Grégoire, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Saint Grégoire, FR 

Overview

Romuald Le Scodan practices practicing medicine in Saint Grégoire, France.

His clinical expertise encompasses Breast Cancer, Colorectal Cancer, Lung Metastases, and Mastectomy.

He is actively involved in clinical research, co-authoring 11 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Saint Grégoire, France
Other Locations
CHRU Brest, Finistère
Brest, France
ICRB VIVALTO SANTE, St Gregoire, Sete, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver
Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver
Enrollment Status: Recruiting
Publish Date: July 09, 2025
Intervention Type: Drug
Study Drugs: Oxaliplatin intravenous, 5 Fu, Folinic Acid, Oxaliplatin intra-arterial, Panitumumab, Bevacizumab
Study Phase: Phase 3
Phase II Study Evaluating the Efficacy and the Safety of Regorafenib in Patients Aged More Than 70 Years Old With a Metastatic Colorectal Adenocarcinoma .
Phase II Study Evaluating the Efficacy and the Safety of Regorafenib in Patients Aged More Than 70 Years Old With a Metastatic Colorectal Adenocarcinoma .
Enrollment Status: Completed
Publish Date: February 23, 2024
Intervention Type: Drug
Study Phase: Phase 2
Phase II Trial Assessing the Efficacy of Immuno-Radiation Abscopal Effect in Patients With Metastatic Cancers (IRAM)
Phase II Trial Assessing the Efficacy of Immuno-Radiation Abscopal Effect in Patients With Metastatic Cancers (IRAM)
Enrollment Status: Withdrawn
Publish Date: January 30, 2020
Intervention Type: Other, Radiation
Study Phase: Phase 2
View 2 Less Clinical Trial

11 Total Publications

Radiotherapy of breast cancer: 2025 update.
Radiotherapy of breast cancer: 2025 update.
Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Published: July 10, 2025

Frequently Asked Questions about Romuald Le Scodan

Is Romuald Le Scodan a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Romuald Le Scodan is classified as an Experienced expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Romuald Le Scodan participate in research or clinical trials?

Yes. Romuald Le Scodan has published 11 articles and abstracts on conditions like Breast Cancer. You can view a list of Romuald Le Scodan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Le Scodan's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile